Scientific Publication

A new study reveals the thriving, high-risk market for compounded weight-loss drugs. Even after FDA shortages ended, some clinics use unregulated suppliers.

A Dutch med-tech firm's sutureless device, validated in a key trial, could make bypass surgery faster, safer, and more accessible via robotics.

South Korea's HIGHER Corp. unveils preclinical data for HILO WAVE®, a dual-hyaluronic acid booster that may bypass the inflammatory pathways of competitors.

A groundbreaking NEJM report shows Neutrolis's therapy rapidly reversed severe Lupus symptoms, validating a new, non-immunosuppressive approach.

A startling case study suggests lifelong heat exposure may build resilience against Alzheimer's. Now, medical researchers are turning to infrared saunas.

Revel's new enzyme reverses a hallmark of aging. This isn't just a lab success; it's a strategic move challenging the very definition of 'irreversible'.

A new medical report confirms artificial stone dust causes a fatal, fast-acting lung disease, finding safety controls inadequate and sparking calls for a ban.

A breakthrough study shows a wearable ear device can stimulate nerves to enhance the body’s natural clotting, offering a drug-free future for saving lives.

An AI infrastructure firm just used its own tech to design safer painkillers, tackling the liver toxicity risks of common drugs. What does this mean for pharma?

A biotech's preclinical success in treating miscarriage is just the start. The real story is its strategy of using pregnancy immunology to target cancer.

With a landmark NEJM publication and FDA approval, Rhythm Pharma's setmelanotide offers hope for a rare obesity, proving a potent strategy for niche markets.

A new study validates a blood test with near-perfect accuracy in MS relapse detection, signaling a strategic shift from imaging to biological data in neurology.

For children with the rare metabolic disorder MMA, a new gene therapy offers hope. Preclinical data reveals a potential one-time fix with lifelong effects.

New long-term data shows a 60-day nerve stimulation treatment helps 8 in 10 patients avoid surgery, challenging the entire strategy for chronic pain.

New guidelines for ankle arthritis, a condition hitting younger workers hard, expose major gaps in medical research and a market ripe for innovation.

Artelo's latest data on its non-opioid pain drug ART26.12 could unlock a massive market, but what are the real risks and rewards for this clinical-stage biotech?

A novel CAR-T therapy from UC Irvine and GlyTR Therapeutics uses a 'velcro-like' mechanism to target solid tumors, a major hurdle in modern oncology.

An Oxford startup's AI-powered blood test can detect cancer and heart disease in dogs from a single sample, heralding a shift from reactive to proactive care.

New imaging data provides the first evidence that a drug-app combo for Parkinson's can induce physical changes in the brain, linking digital therapy to better outcomes.

A new chapter in materials science signals a major shift from metal to 3D woven composites, promising lighter, stronger, and more efficient aircraft.